Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
e-Therapeutics PLC (ETX LN)
Watchlist
13
Analysis
Health Care
•
United Kingdom
e-Therapeutics PLC is a systems biology drug discovery company. The Company uses computers to predict the effects of intervention to proteins in a cell.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
e-Therapeutics PLC
•
08 Oct 2018 17:02
•
Issuer-paid
e-Therapeutics - Keeping the faith
e-Therapeutics’ (ETX) H118 results were a routine financial update highlighting its continuing focus on partnering the Network-driven Drug...
Edison Investment Research
Follow
43 Views
Share
bullish
•
e-Therapeutics PLC
•
23 Apr 2018 17:20
•
Issuer-paid
e-Therapeutics - A matter of time until prime time
With the refocusing of the business and the new CEO’s strategic review now implemented, e-Therapeutics (ETX) finds itself with the NDD platform and...
Edison Investment Research
Follow
57 Views
Share
bullish
•
e-Therapeutics PLC
•
05 Jan 2018 20:21
•
Issuer-paid
e-Therapeutics - Nearing prime time validation
e-Therapeutics’ (ETX) Network-Driven Drug Discovery (NDD) platform has begun to deliver encouraging data that should support out-licensing of its...
Edison Investment Research
Follow
60 Views
Share
bullish
•
e-Therapeutics PLC
•
04 Oct 2017 22:33
•
Issuer-paid
Sailing a steady course
e-Therapeutics’ (ETX) interim numbers demonstrate tight cost control and focus on the rationalised pipeline, with continued investment into the...
Edison Investment Research
Follow
56 Views
Share
bullish
•
e-Therapeutics PLC
•
27 Jul 2017 16:00
•
Issuer-paid
Strategic review complete: focus on deal-making
New CEO Dr Ray Barlow, who joined e-Therapeutics (ETX) in April, has undertaken a business and strategic review, assisted by an independent...
Edison Investment Research
Follow
78 Views
Share
Previous
1
2
3
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x